Company Overview - Veeva Systems Inc. is a significant player in the cloud-based software industry, primarily serving the life sciences sector with solutions for customer relationship management, content management, and data analytics [1] - Competitors include Oracle and Salesforce, which also provide cloud-based solutions across various industries [1] Recent Performance - On December 11, 2025, KeyBanc downgraded Veeva Systems to a Sector Weight rating, with the stock priced at $229.47, amid a challenging period for the company [2] - Veeva's shares have declined by 22.8% over the past month, contrasting with a slight increase of 0.9% in the Zacks S&P 500 composite, indicating underperformance [2][6] - The Zacks Medical Info Systems industry, which includes Veeva, has faced a downturn with a loss of 9.3% during the same period [3] Market Metrics - Veeva's market capitalization is approximately $37.72 billion, reflecting its significant presence in the industry [4] - The stock has experienced a 52-week high of $310.50 and a low of $201.54, indicating considerable volatility [4] - Today's trading volume for VEEV is 1,521,286 shares, suggesting active investor engagement despite recent challenges [4][6] Investor Sentiment - Despite the recent downgrade and market performance, Veeva remains a trending stock on Zacks.com, indicating continued interest from investors [3][6] - Fundamental factors like earnings estimate revisions are crucial for long-term investment decisions, which investors should consider when evaluating Veeva's future prospects [5]

Core Insights - Genpact reported Q3 CY2025 results that exceeded market revenue expectations, with a year-on-year sales increase of 6.6% to $1.29 billion, surpassing analyst estimates by 2% [1][7][8] - The company provided better-than-expected revenue guidance for the next quarter at $1.30 billion, which is 1.2% above analysts' estimates [1][7] - Non-GAAP profit per share was $0.97, which is 8% higher than analysts' consensus estimates [1][7] Company Overview - Genpact, originally spun off from General Electric in 2005, is a global professional services firm focused on transforming business operations through digital technology, AI, and data analytics solutions [3] Revenue Growth - Over the past 12 months, Genpact generated $5.01 billion in revenue, positioning it as one of the larger companies in the business services industry [4] - The company has achieved a compounded annual growth rate of 6.2% in sales over the last five years, indicating a consistent demand for its offerings [5] - Genpact's annualized revenue growth of 6.3% over the last two years aligns with its five-year trend, suggesting stable demand [6] Financial Highlights - Q3 CY2025 revenue was $1.29 billion, compared to analyst estimates of $1.27 billion, reflecting a 6.6% year-on-year growth [7] - Adjusted EPS was $0.97, beating analyst estimates of $0.90 by 8% [7] - Adjusted EBITDA was $222.1 million, with a margin of 17.2%, which was a 5.7% miss compared to analyst estimates [7] - Management raised its full-year Adjusted EPS guidance to $3.61, a 1.7% increase [7] - Operating margin remained stable at 14.8%, while free cash flow margin improved to 22.6%, up from 17.2% in the same quarter last year [7] Future Outlook - Management is guiding for a 4.5% year-on-year increase in sales for the next quarter [8] - Sell-side analysts expect revenue to grow 5.2% over the next 12 months, which is above average for the sector, indicating potential success for Genpact's newer products and services [9]

Company Overview - Leidos Holdings, Inc. is a global science and technology leader founded in 1969, serving defense, intelligence, civil, and health markets [11] - The company specializes in cybersecurity, data analytics, enterprise IT modernization, operations and logistics, sensors, software development, and systems engineering [11] Investment Ratings - Leidos is currently rated 2 (Buy) on the Zacks Rank, indicating a favorable investment outlook [12] - The company has a VGM Score of A, suggesting strong overall performance across value, growth, and momentum metrics [12] Performance Metrics - Leidos has a Momentum Style Score of B, with shares increasing by 9.3% over the past four weeks [12] - Five analysts have revised their earnings estimates upwards for fiscal 2025, with the Zacks Consensus Estimate rising by $0.37 to $11.07 per share [12] - The company boasts an average earnings surprise of +25.1%, indicating strong performance relative to expectations [12] Investment Considerations - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, Leidos is recommended for investors' consideration [13]

As filed with the U.S. Securities and Exchange Commission on June 20, 2025. Registration No. 333-287134 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Platinum Analytics Cayman Limited (Exact name of registrant as specified in its charter) | Cayman Islands | 6289 | Not Applicable | | --- | --- | --- | | (State or other jurisdiction of | (Primary Standard Industrial | (I.R.S. Employer | | incorporatio ...

As filed with the U.S. Securities and Exchange Commission on May 9, 2025. Registration No. 333-[●] UNDER THE SECURITIES ACT OF 1933 Platinum Analytics Cayman Limited (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT | | | (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (Address, including zip code, and telephone number, including ...